The University of Southampton
University of Southampton Institutional Repository

Artificial nucleic acid backbones and their applications in therapeutics, synthetic biology and biotechnology

Artificial nucleic acid backbones and their applications in therapeutics, synthetic biology and biotechnology
Artificial nucleic acid backbones and their applications in therapeutics, synthetic biology and biotechnology
The modification of DNA or RNA backbones is an emerging technology for therapeutic oligonucleotides, synthetic biology and biotechnology. Despite a plethora of reported artificial backbones, their vast potential is not fully utilised. Limited synthetic accessibility remains a major bottleneck for the wider application of backbone-modified oligonucleotides. Thus, a variety of readily accessible artificial backbones and robust methods for their introduction into oligonucleotides are urgently needed to utilise their full potential in therapeutics, synthetic biology and biotechnology.
2397-8562
691–697
Epple, Sven
0a1f70bd-7366-48a9-a1ee-7d747ff652ab
El-Sagheer, Afaf
05b8295a-64ad-4fdf-ad57-c34934a46c04
Brown, Tom
a64aae36-bb30-42df-88a2-11be394e8c89
Epple, Sven
0a1f70bd-7366-48a9-a1ee-7d747ff652ab
El-Sagheer, Afaf
05b8295a-64ad-4fdf-ad57-c34934a46c04
Brown, Tom
a64aae36-bb30-42df-88a2-11be394e8c89

Epple, Sven, El-Sagheer, Afaf and Brown, Tom (2021) Artificial nucleic acid backbones and their applications in therapeutics, synthetic biology and biotechnology. Emerging Topics in Life Sciences, 5 (5), 691–697. (doi:10.1042/ETLS20210169).

Record type: Article

Abstract

The modification of DNA or RNA backbones is an emerging technology for therapeutic oligonucleotides, synthetic biology and biotechnology. Despite a plethora of reported artificial backbones, their vast potential is not fully utilised. Limited synthetic accessibility remains a major bottleneck for the wider application of backbone-modified oligonucleotides. Thus, a variety of readily accessible artificial backbones and robust methods for their introduction into oligonucleotides are urgently needed to utilise their full potential in therapeutics, synthetic biology and biotechnology.

Text
etls-2021-0169c - Version of Record
Available under License Creative Commons Attribution.
Download (4MB)

More information

Accepted/In Press date: 14 July 2021
e-pub ahead of print date: 23 July 2021
Published date: 1 November 2021

Identifiers

Local EPrints ID: 477928
URI: http://eprints.soton.ac.uk/id/eprint/477928
ISSN: 2397-8562
PURE UUID: a629cd80-c36b-4242-bcb7-595f1cf9a03c
ORCID for Afaf El-Sagheer: ORCID iD orcid.org/0000-0001-8706-1292

Catalogue record

Date deposited: 16 Jun 2023 16:42
Last modified: 28 Aug 2024 01:40

Export record

Altmetrics

Contributors

Author: Sven Epple
Author: Afaf El-Sagheer ORCID iD
Author: Tom Brown

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×